SCHEMBL25663197

SCHEMBL25663197

c1ccc2nnc(-c3ccc(N(c4ccc(-c5cc6ccccc6nn5)cc4)c4ccc(-c5ccc6c(n5)sc5ccccc56)cc4)cc3)cc2c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ APP P05067 1/20 0.35
▸ NPC1 O15118 4/20 0.33
▸ RAB9A P51151 4/20 0.33
▸ SMN1; SMN2 Q16637 3/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ NFKB1 P19838 1/20 0.33
▸ NFKB2 Q00653 1/20 0.33
▸ RELA Q04206 1/20 0.33
▸ LIMK1 P53667 2/20 0.32
▸ ELANE P08246 1/20 0.31
▸ MEN1 O00255 2/20 0.31
▸ KMT2A Q03164 2/20 0.31
▸ KDM4E B2RXH2 2/20 0.31
▸ HPGD P15428 2/20 0.31
▸ AR P10275 1/20 0.31
▸ GMNN O75496 1/20 0.30
▸ TP53 P04637 1/20 0.30
▸ CYP3A4 P08684 1/20 0.30
▸ MAPT P10636 1/20 0.30
▸ PKM P14618 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25663221 0.88 RAB9A (0.39) APPNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL25663184 0.87 RAB9A (0.44) APPNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL25663224 0.85 RAB9A (0.33) APPNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL25663188 0.84 PDGFRB (0.42) APP
SCHEMBL24055864 0.84 NPC1 (0.42) APPNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL25663185 0.84 NPC1 (0.42) NPC1RAB9ASMN1; SMN2ALDH1A1NFKB1
SCHEMBL25663216 0.83 APP (0.54) APPNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL25663228 0.83 ALDH1A1 (0.36) APPNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL25663222 0.83 RAB9A (0.35) APPNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL25663220 0.83 RAB9A (0.38) APPNPC1RAB9ASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2023-06-01 — — US disclosed
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2023-06-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE CHRM1, CHRM2, CHRM4 APP 2850/4885NPC1 3859/4885RAB9A 2198/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback